SEO URLwww.firestrike.ai/deals/zydus-agenus-acquisition-2026
acquisitionAnnounced · Jan 15, 2026immuno-oncologySource · CredibleArticle · Factual
Agenus acquires Zydus
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$141M
Target
Zydus
Acquirer
Agenus
Asset/Business Division Sale
Status
Completed
Agenus agreed to acquire Zydus. Reported deal value: $141M. Status: Completed. Sector: immuno-oncology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-15. Figures and status may change as filings and press coverage update.
07:01 AM , with Agenus eligible to receive a 5% royalty on net sales in those territories Closing this collaboration with Zydus strengthens our balance sheet and, critically, secures dedicated U
Deal timeline
Announced
Jan 15, 2026 · stocktitan.net
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in immuno-oncology with a reported deal value of $141M. Figures and status may change as sources update.
Sources: stocktitan.net · Primary article · FireStrike proprietary index